Apolipoproteins and ischaemic heart disease: implications for screening
- 8 January 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8889) , 75-79
- https://doi.org/10.1016/s0140-6736(94)90814-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA studyBMJ, 1994
- Predictive value of apolipoproteins in a prospective survey of coronary artery disease in menThe American Journal of Cardiology, 1992
- A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial InfarctionNew England Journal of Medicine, 1991
- Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participantsAtherosclerosis, 1991
- Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.BMJ, 1990
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery diseaseThe American Journal of Cardiology, 1985
- Mortality in relation to smoking: 20 years' observations on male British doctors.BMJ, 1976